论文部分内容阅读
AIM:To expand the living donor liver transplantation(LT)pool of eligible patients with hepatocellular carcinoma(HCC)using new morphological and biological criteria.METHODS:Patients with HCC who underwent living donor LT(LDLT)from March 2005 to May 2013 at